David Smart / Shutterstock.com
13 January 2020AmericasRory O'Neill
California mulls state generics brand
California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.
Americas
3 January 2020 A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.
Editor's picks
Editor's picks
Americas
9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.
Americas
3 January 2020 A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.
Americas
9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.
Americas
3 January 2020 A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.